StockData
Savara Inc logo

Savara Inc (SVRA) stock

SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.72+0.24 (+5.36%)

Close on Nov 18, 2026Market cap $969.77MP/E –Yield –

Savara revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Savara's revenue for the twelve months ending Dec 31, 2020 was $257.00K. For fiscal 2020 it was $257.00K. The highest annual figure on record is $488.96K in fiscal 2010.

Annual revenue

PeriodPeriod endValueChange
FY2020Dec 31, 2020$257.00K–
FY2019Dec 31, 2019$0–
FY2017Dec 31, 2017$0-100.0%
FY2016Dec 31, 2016$400.00K+640.7%
FY2015Dec 31, 2015$54.00K–
FY2014Dec 31, 2014$0–
FY2013Dec 31, 2013$0–
FY2012Dec 31, 2012$0-100.0%
FY2010Dec 31, 2010$488.96K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2021Sep 30, 2021$0–
Q4 FY2020Dec 31, 2020$1.00K–
Q3 FY2020Sep 30, 2020$256.00K–
Q2 FY2020Jun 30, 2020$0–
Q1 FY2020Mar 31, 2020$0–
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$0-100.0%
Q1 FY2018Mar 31, 2018$0-100.0%
Q4 FY2017Dec 31, 2017$0-100.0%
Q3 FY2017Sep 30, 2017$0–
Q1 FY2017Mar 31, 2017$94.00K–
Q4 FY2016Dec 31, 2016$400.00K–
Q3 FY2016Sep 30, 2016$45.00K–

More Savara figures

See a number that looks wrong?